A new study reports that since the implementation of Medicare Part D, fewer beneficiaries with glaucoma are resorting to cost-saving medication measures, such as taking smaller doses or skipping doses.
CMS issues ruling related to DOMA demise ... President Obama criticizes Staples for approach to healthcare coverage ... Glaucoma patients have better adherence with generic drug, study finds
It's rare that results of a new study, especially with a product focus, excite me. That's not to say I don't appreciate reading about a vendor's award, or the latest Alzheimer's study, but I see these more objectively than, say, the release Monday about a new option for glaucoma treatment. That's news where I thought, "Wow!"
A contact lens that can deliver glaucoma medication may signal a new era for treatment of the eye disease. Researchers at Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology, Boston Children's Hospital and Massachusetts Institute of Technology developed a lens that can deliver large amounts of latanoprost, which is a common glaucoma treatment drug.